<DOC>
	<DOCNO>NCT00727259</DOCNO>
	<brief_summary>The current gold standard treatment chronic hepatitis C ( CHC ) patient pegylated interferon plus ribavirin . Drug administration accuracy ease use definitely determine treatment effectiveness . This idea behind development usage PegPen . The goal study determine satisfaction grade novel device .</brief_summary>
	<brief_title>Evaluation Satisfaction Patients Receiving PegIntron Pen/Rebetol Hepatitis C ( Study P04067 )</brief_title>
	<detailed_description>Enrollment patient occur sequential order treatment initiation .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient hepatitis C According product ' labeling .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>